# US 2013/0158658 A1 · Sheet tissue products

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0158658 A1
- Document ID: US20130158658A1
- Status: Published application
- Kind: A1
- Application number: 13/717,828
- Filed: 2012-12-18
- Published: 2013-06-20
- Earliest claimed: 2011-12-20
- Assignees: LifeCell Corporation
- Inventors: Mark Hayzlett
- Web page: https://patentgrep.com/patent/US20130158658A1

## CPC

- A61F 2/08: Muscles; Tendons; Ligaments
- A61L 27/52: Hydrogels or hydrocolloids
- A61F 2/02: Prostheses implantable into the body
- A61F 2/105: {Skin implants, e.g. artificial skin}
- A61F 2/12: Mammary prostheses
- A61F 2/28: Bones
- A61F 2/30756: {Cartilage endoprostheses (A61F2/3603 takes precedence)}
- A61L 27/362: {Skin, e.g. dermal papillae}
- A61L 27/3683: {subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment}
- A61L 27/3695: {characterised by the function or physical properties of the final product, where no specific conditions are defined to achieve this (A61L27/3687, A61L27/3691 take precedence)}
- A61L 27/56: Porous materials, {e.g. foams or sponges}
- C08J 3/075: Macromolecular gels
- C08J 3/24: Crosslinking, e.g. vulcanising, of macromolecules (mechanical aspects B29C35/00; crosslinking agents C08K)
- A61F 2/2846: {Support means for bone substitute or for bone graft implants, e.g. membranes or plates for covering bone defects (nets or sleeves applied to surface of endoprostheses A61F2/30907; bone plates A61B17/80; bone regeneration in dental surgery A61C8/0006)}
- A61F 2002/30766: {Scaffolds for cartilage ingrowth and regeneration}
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C08J: WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H (working, e.g. shaping, of plastics B29)

## Abstract

The present disclosure provides a tissue product comprising a tissue sheet. The sheet can be formed from a plurality of tissue matrix fragments.

## Claims

### Claim 1

A tissue sheet product, comprising:
a sheet of material, wherein the sheet comprises a plurality of tissue matrix fragments having a length between about 5 μm and 300 μm, wherein the tissue matrix fragments are joined to one another to form the tissue sheet.

### Claim 2 (depends on 1)

The tissue product of claim 1, wherein the fragments are joined without use of a binder or adhesive.

### Claim 3 (depends on 1)

The tissue product of claim 1, wherein the fragments are joined by convective drying.

### Claim 4 (depends on 1)

The tissue product of claim 1, wherein the tissue fragments are cross-linked to one another.

### Claim 5 (depends on 4)

The tissue product of claim 4, wherein the tissue fragments are cross-linked to one another using a dehydrothermal crosslinking process.

### Claim 6 (depends on 1)

The tissue product of claim 1, wherein the fragments are produced from acellular tissue matrix.

### Claim 7 (depends on 1)

The tissue product of claim 1, wherein the sheet swells when contacted with water.

### Claim 8 (depends on 1)

The tissue product of claim 1, wherein the sheet forms a porous structure with open channels that can support cellular ingrowth and vascularization.

### Claim 9 (depends on 1)

The tissue product of claim 1, wherein the tissue fragments are elongated strands of tissue matrix.

### Claim 10 (depends on 1)

The tissue product of claim 1, wherein the tissue matrix is dermal tissue matrix.

### Claim 11 (depends on 1)

The tissue product of claim 1, wherein the tissue matrix is porcine tissue matrix.

### Claim 12 (depends on 1)

The tissue product of claim 1, wherein the sheet is dry.

### Claim 13 (depends on 1)

The tissue product of claim 1, wherein the sheet is hydrated and flexible.

### Claim 14

A method for producing a tissue treatment composition, comprising:
treating a tissue matrix to produce fragments having a length between about 5 μm and 300 μm;
forming the fragments into a sheet; and
treating the sheet to join the fragments to one another.

### Claim 15 (depends on 14)

The method of claim 14, further comprising drying the sheet.

### Claim 16 (depends on 15)

The method of claim 15, wherein drying includes subjecting the sheet to a convective drying process.

### Claim 17 (depends on 15)

The method of claim 15, wherein treating the sheet to join the fragments includes treating the sheet with a dehydrothermal treatment process.

### Claim 18 (depends on 14)

The method of claim 14, wherein forming the fragments into a sheet includes compressing groups of the fragments.

### Claim 19 (depends on 14)

The method of claim 14, wherein treating the tissue matrix to produce fragments includes milling the tissue matrix.

### Claim 20 (depends on 14)

The method of claim 14, wherein the fragments are strands of tissue matrix.

### Claim 21 (depends on 14)

The method of claim 14, wherein the tissue matrix is dermal tissue matrix.

### Claim 22 (depends on 14)

The method of claim 14, wherein the tissue matrix is porcine tissue matrix.

### Claim 23 (depends on 14)

The method of claim 14, wherein the tissue matrix is acellular tissue matrix.

### Claim 24 (depends on 14)

A tissue sheet product, comprising:
a sheet made by the method of any one of claim 14.

### Claim 25

A method of treating a tissue site, comprising:
selecting a tissue product, comprising a plurality of tissue matrix fragments having a length between about 5 μm and 300 μm, wherein the tissue matrix fragments are joined to one another to form the sheet; and
placing the sheet in or on the tissue site.

### Claim 26 (depends on 25)

The method of claim 25, further comprising removing tissue from the tissue site before placing the sheet in or on the tissue site.

### Claim 27 (depends on 25)

The method of claim 25, wherein the tissue site is a lumpectomy site.

### Claim 28 (depends on 25)

The method of claim 25, wherein the tissue site is selected from at least one of breast, a portion of an abdominal wall, a connective tissue, a tendon, a ligament, dermis, dura, cartilage, bone, gingiva, and adipose tissue.

### Claim 29 (depends on 25)

The method of claim 25, further comprising applying reduced pressure therapy to the tissue site.

### Claim 30 (depends on 25)

The method of claim 25, wherein the tissue matrix includes dermal tissue matrix.

### Claim 31 (depends on 25)

The method of claim 25, wherein the tissue matrix includes porcine tissue matrix.

### Claim 32 (depends on 25)

The method of claim 25, wherein the tissue matrix includes acellular tissue matrix.
